About

About us

"AlphaMol accelerates GPCR drug discovery in an ultimately efficient way"

AlphaMol attracts leading scientists in the areas of both biological computing and pharmaceutical sciences to join the team. We develop cutting-edge bio-technologies to substantially speed up modern drug discovery. We aim at challenging essential diseases in human health.

AlphaMol has sites in Allschwil Switzerland as well as in Shanghai and Shenzhen in China.

Shuguang Yuan

Cofounder

PhD in EPFL, KULeuven and Polish Academy of Sciences. Master in the Shanghai Institute of Organic Chemistry, CAS.

Horst Vogel

Cofounder

Emeritus professor in the Swiss Federal Institute of Technology (EPFL), Lausanne. Member of the Swiss Academy of Sciences.

Shouguo Wang

Senior Medchem Officer

Postdoc in EPFL, Switzerland. PhD in the Shanghai Institute of Organic Chemistry, CAS.

Zhenquan Hu

Senior Computational Biologist

Phd in the University of Basel, Switzerland. Master in Shanghai Institute of Organic Chemistry, CAS.

Qing Pan

Senior Scientist in Biochemistry

PhD in the University of Hong Kong, China.

Yanping Wang

Junior data scientist in AI drug discovery

Master in Rutgers, the State University of New Jersey, USA

Marc Xu

Scientist in AI Drug Discovery

Master in the University of Paris, France.

Yongyin Chen

Scientist in Medchem

Master in the Imperial College London, UK.

Nathan Chen

CEO Assistant

Master in the Swiss Hotel Management School, Switzerland.